{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Corvallis",
      "state": "OR",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "82278",
      "recalling_firm": "Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy",
      "address_1": "996 Nw Circle Blvd Ste 105",
      "address_2": "N/A",
      "postal_code": "97330-1485",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Telephone",
      "distribution_pattern": "Dispensed in Oregon",
      "recall_number": "D-1089-2019",
      "product_description": "HYDROXYPROGESTERONE CAPROATE 250 MG/ML OIL*  INJECTABLE, (a) 10ml (b) 9ml injectable,  Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330 .",
      "product_quantity": "4 prescriptions 9 & 10ml injectable",
      "reason_for_recall": "Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.",
      "recall_initiation_date": "20190221",
      "center_classification_date": "20190409",
      "termination_date": "20200723",
      "report_date": "20190417",
      "code_info": "Lots: (a) 01112018@19, 04012019@52,  14022019@23, (b) 14012019@36,   distributed between 09-01-2018 to 02-20-2019."
    }
  ]
}